Hepatitis C in Lebanon: the burden of the disease and the value of comprehensive screening and treatment
Antoine Abou Rached,1 Selim Abou Kheir,1 Jowana Saba,1 Salwa Assaf,2 Georges Kassis,3 Yuri Sanchez Gonzalez,4 Olivier Ethgen5,6 1Faculty of Medicine, School of Medicine, Lebanese University, Beirut, Lebanon; 2Abbvie Biopharmaceuticals GmbH, Beirut, Lebanon; 3Abbvie Biopharmaceuticals, Paris, France;...
Guardado en:
Autores principales: | Abou Rached A, Abou Kheir S, Saba J, Assaf S, Kassis G, Sanchez Gonzalez Y, Ethgen O |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8739804e6ef54baf9f625f6318463cce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepatitis C infection in Egypt: prevalence, impact and management strategies
por: Gomaa A, et al.
Publicado: (2017) -
Hepatitis C in the Russian Federation: challenges and future directions
por: Mukomolov S, et al.
Publicado: (2016) -
Association between hepatic fat and subclinical vascular disease burden in the general population
por: Susanne Rospleszcz, et al.
Publicado: (2021) -
Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain
por: Abdulla MA, et al.
Publicado: (2017) -
Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia MD, et al.
Publicado: (2011)